SRDX - יחס חוב להיוון בספרים Surmodics Inc

Supply chain disruptions and sanctions are limiting access to new sales markets for therapeutic devices. However, an aging population and the complexity of procedures are driving B2B demand, where the indicator stands at 0.31. Surmodics, Inc. (SRDX) relies on its own facilities in Ireland and the US to produce sterile coatings and catheters. This chart illustrates the price action for SRDX shares below.

Surmodics, Inc. (SRDX) benefits from stable demand for medtech, allowing it to maintain resilience regardless of market cycles. The debt-to-book ratio measures the business's degree of financial autonomy, helping investors assess the balance between scaling and debt load via the debt capitalization coverage ratio.